Schoenen J - Search Results

1

Pathophysiological targets for non-pharmacological treatment of migraine.

Coppola G, Di Lorenzo C, Serrao M, Parisi V, Schoenen J, Pierelli F. Coppola G, et al. Among authors: schoenen j. Cephalalgia. 2016 Oct;36(12):1103-1111. doi: 10.1177/0333102415620908. Epub 2016 Jul 19. Cephalalgia. 2016. PMID: 26637237 Free article. Review.

2

Blood magnesium levels in migraine.

Schoenen J, Sianard-Gainko J, Lenaerts M. Schoenen J, et al. Cephalalgia. 1991 May;11(2):97-9. doi: 10.1046/j.1468-2982.1991.1102097.x. Cephalalgia. 1991. PMID: 1860136

3

Contingent Negative Variation in migraine.

Böcker KB, Timsit-Berthier M, Schoenen J, Brunia CH. Böcker KB, et al. Among authors: schoenen j. Headache. 1990 Sep;30(9):604-9. doi: 10.1111/j.1526-4610.1990.hed3009604.x. Headache. 1990. PMID: 2262316

4

Clinical neurophysiology and neurotransmitters.

Maertens de Noordhout A, Wang W, Schoenen J. Maertens de Noordhout A, et al. Among authors: schoenen j. Cephalalgia. 1995;15(4):301-9. doi: 10.1046/j.1468-2982.1995.1504301.x. Cephalalgia. 1995. PMID: 7585928

5

High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study.

Schoenen J, Lenaerts M, Bastings E. Schoenen J, et al. Cephalalgia. 1994 Oct;14(5):328-9. doi: 10.1046/j.1468-2982.1994.1405328.x. Cephalalgia. 1994. PMID: 7828189 Clinical Trial.

6

Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study.

Schoenen J, Bulcke J, Caekebeke J, Dehaene I, De Keyser J, Hildebrand G, Joffroy A, Laloux P, Louis P, Monseu G, et al. Schoenen J, et al. Cephalalgia. 1994 Feb;14(1):55-63. doi: 10.1046/j.1468-2982.1994.1401055.x. Cephalalgia. 1994. PMID: 8200027 Clinical Trial.

7

Measuring central action of acute antimigraine drugs in humans.

Schoenen J. Schoenen J. Cephalalgia. 1997 Jun;17 Suppl 17:12-5; discussion 15-6. doi: 10.1177/0333102497017S1705. Cephalalgia. 1997. PMID: 9218880 No abstract available.

8

Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data.

Mascia A, Afra J, Schoenen J. Mascia A, et al. Among authors: schoenen j. Cephalalgia. 1998 May;18(4):174-82. doi: 10.1046/j.1468-2982.1998.1804174.x. Cephalalgia. 1998. PMID: 9642491 Review.

9

Interictal potentiation of passive "oddball" auditory event-related potentials in migraine.

Wang W, Schoenen J. Wang W, et al. Among authors: schoenen j. Cephalalgia. 1998 Jun;18(5):261-5; discussion 241. doi: 10.1046/j.1468-2982.1998.1805261.x. Cephalalgia. 1998. PMID: 9673805

10

Prophylactic treatment of migraine with beta-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials.

Sándor PS, Afra J, Ambrosini A, Schoenen J. Sándor PS, et al. Among authors: schoenen j. Headache. 2000 Jan;40(1):30-5. doi: 10.1046/j.1526-4610.2000.00005.x. Headache. 2000. PMID: 10759900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

451 results

Search Page